Brian Elsbernd, Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 50,000 shares at $16.44 ($822K) on 2024-03-27, disclosed to the SEC on 2024-03-28.
Open-market sale of $822k CPRX by Chief Compliance/Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.44 | 25,000 | $411K | 50.0% |
| 2 | $16.44 | 25,000 | $411K | 50.0% |
| Total | $16.44 avg | 50,000 | $822K | 100% |
| Filing → |
| CPRX | SELL | 2025-09-05 | $1.4M | — | Filing → |
| CPRX | SELL | 2025-03-05 | $2.9M | — | Filing → |
| CPRX | SELL | 2024-11-29 | $372K | — | Filing → |